Product Evaluation and Registration Unit, National Medicine and Food Administration, Ministry of Health, Asmara, Eritrea.
Department of Pharmacy, Adi-Tekelezan Community Hospital, Ministry of Health, Adi-Tekelezan, Eritrea.
Clin Interv Aging. 2024 Jul 1;19:1177-1187. doi: 10.2147/CIA.S466649. eCollection 2024.
Potentially inappropriate medication (PIM) use is one of the main drug-related problems encountered in older adults. It is associated with adverse drug events, morbidity, mortality, increased economic costs, and negative effects on the quality of life that requires strict monitoring of prescriptions in older adults. Thus, the study aimed to assess potentially inappropriate medication use and its determinants among older adults.
A cross-sectional study was conducted among all outpatient prescriptions dispensed to older adults (aged 65 years and above) in six community chain pharmacies in Asmara, Eritrea. Data were collected retrospectively, between June 16 and July 16, 2023. PIMs were detected using the 2023 American Geriatric Society (AGS) Beers Criteria. Descriptive statistics and logistic regression analysis were performed using IBM SPSS (Version-26.0).
A total of 2680 outpatient prescriptions dispensed to older adults were included in this study. The prevalence of PIM among prescriptions was 18.1% (95% CI: 16.7, 19.6). Moreover, a total of 470 medications were found to be avoided in older adults. The most commonly prescribed PIMs were sulfonylureas (27.2%) and substituted alkylamines (16.2%). The prevalence of prescriptions containing medications to be used with caution in older adults was 13.2% (95% CI: 12.0, 14.5). Age (Adjusted Odds Ratio (AOR))=0.98, 95% CI: 0.97, 0.99), polypharmacy (AOR=2.77, 95% CI: 1.49, 5.15), and general practitioner prescriber (AOR=1.38, 95% CI: 1.11, 1.70) were significantly associated with PIMs.
A considerable number of ambulatory older adults were exposed to PIMs which require a close attention by policymakers, program managers, and healthcare professionals.
潜在不适当药物(PIM)的使用是老年人中遇到的主要药物相关问题之一。它与药物不良事件、发病率、死亡率、增加的经济成本以及对生活质量的负面影响有关,需要严格监测老年人的处方。因此,本研究旨在评估老年人中潜在不适当药物的使用及其决定因素。
本横断面研究于 2023 年 6 月 16 日至 7 月 16 日在厄立特里亚阿斯马拉的六家社区连锁药店对所有开给老年人(65 岁及以上)的门诊处方进行。数据是回顾性收集的。使用 2023 年美国老年医学会(AGS)Beers 标准检测潜在不适当药物。使用 IBM SPSS(版本 26.0)进行描述性统计和逻辑回归分析。
本研究共纳入 2680 份开给老年人的门诊处方。处方中潜在不适当药物的患病率为 18.1%(95%CI:16.7,19.6)。此外,共发现 470 种药物避免在老年人中使用。最常开的潜在不适当药物是磺酰脲类(27.2%)和取代烷基胺类(16.2%)。含有谨慎使用药物的处方的患病率为 13.2%(95%CI:12.0,14.5)。年龄(调整后的优势比(AOR))=0.98,95%CI:0.97,0.99)、多药治疗(AOR=2.77,95%CI:1.49,5.15)和全科医生处方者(AOR=1.38,95%CI:1.11,1.70)与潜在不适当药物显著相关。
相当数量的门诊老年人接触到潜在不适当药物,这需要政策制定者、项目管理者和医疗保健专业人员密切关注。